bpc 157 prohealth Longevity ProHealth Longevity BPC-157, 500 mcg,
ProHealth Longevity BPC 157, 500 mcg, 60 Capsules : Target Novo Nordisk, maker of the popular medications Ozempic and Wegovy, filed a lawsuit Tuesday against the pharmaceutical company Eli Lilly, accusing it of making deceptive advertising claims about its weight loss drug Zepbound. Photo by Wellblm (@wellblumgroup) November 16, 2025 Novo Nordisk is suing Eli Lilly over its GLP 1 ads, accusing the rival drugmaker of false advertising for claiming Lilly's Mounjaro and Zepbound outperform Novo's Ozempic and Wegovy. MORE BELOW
Pay in 4 interest-free payments of $6.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7